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ABSTRACT
Vernonia amygdalina (VA) is a tropical African plant of the Asteraceae family
used as dietary supplement and as a medicinal herb. In this study, fatty acid
esters, fatty acid amide, triterpene, diterpene alcohols and phytostanols were
identified as the major chemical groups in the aqueous and organic fractions of
VA leaf extracts. Their structures were elucidated, on the basis of GC-MS data,
as hexanedioic acid, bis (2-ethylhexyl) ester (2a), erucamide (2b) and squalene
(2c) in the water fraction; hexadecanoic acid methyl ester (3a), 9(Z)12(Z)15(Z)octadecatrienoic acid, methyl ester (3b) and phytol (3c) in methanol fraction;
phytol (4a), squalene (4b) and 7,22-ergostadienol (4c) in the petroleum ether
fraction. Diterpene alcohol and aliphatic acid esters were higher in relative
content than triterpene, fatty acid amide, and phytostanol in VA leaf extracts. In
vitro evaluation of anti-proliferative activities of sample extracts on MDA-MB231 cells revealed significant growth inhibition by methanol (45-70%, P < 0.001)
and petroleum ether (70-97%, P < 0.001) fractions, compared to aqueous fraction
(11-23%, P < 0.05).

1. INTRODUCTION
Vernonia amygdalina, one of the species of
the genius Vernonia, belongs to the
Asteraceae family. As a perennial shrub, it
has been consumed as vegetable food and
used in African folk medicine to treat
various diseases and infections. In the wild,
it has been consumed by Chimpanzees
suffering from parasitic infections [1].
Previous studies have showed that VA leaf
extracts are effective against amoebic
dysentery and gastrointestinal disorders [28], microbial and parasitic infections [8,9],
hepatoxities [10] and cancer [11-16]. These
biological activities may be attributed to
various chemical classes [17-22]. Recently,
we isolated and identified, in VA, steroid
glucosides with anti-proliferative activities in
ER+ human breast adrenocarcinoma (MCF7) cells [23]. Detection and analyses of these
groups of compounds have relied on various
chromatographic
and
spectrometric
techniques such as TLC, UV, IR, NMR, etc.
In our continued investigation of secondary
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metabolites in VA, we have hereby
identified fatty acid esters, fatty acid amide,
triterpene,
diterpene
alcohols
and
phytostanols in aqueous, methanol and
petroleum ether extracts, utilizing a highly
sensitive and specific detection technique,
GC-MS. Extraction, fractionation and
structure elucidation of these compounds
involved liquid-liquid extraction, solvent
partitioning, and analysis of electron impact
(EI) mass fragmentation patterns of their
ions.
2. MATERIALS AND METHODS
2.1 General Experimental Procedures
All chromatographic experiments were by
GC-MS. An Agilent Technologies 6890 GC
(CA, USA) interfaced with an Agilent 5973
Inert Mass Selective Detector was used to
generate data. A Supelco fused-silica SPB-1
(30 m, 0.32-mm i.d., 0.25 µm film) column
(Bellefonte, PA, USA) was used for highresolution capillary gas chromatography.
Oven temperature was programmed from 40
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to 300°C at 20°C/min, and helium was used
as the carrier gas. RPMI-1640 Medium was
supplied by Gibco BRL (Grand Island, NY).
Trypsin-EDTA,
heat-inactivated
Fetal
Bovine
Serum
(FBS),
penicillin,
streptomycin and fungizone were supplied
by Sigma Chemicals Co. (St. Louis, MO).
MTT reagent was supplied by Invitrogen Co.
(Carlsbad, CA). Sterile 0.45 µm and 0.2 µm
filters were purchased from Corning
(Corning, NY). All other chemicals were of
analytical grade and supplied by Sigma
Chemicals Co. (St. Louis, MO, USA).
2.2 Plant Material and Solvent Extraction
Stem cuttings of Vernonia amygdalina
(family: Asteraceae), identified by Dr.
Broderick Eribo were cultivated in the green
house, Department of Biology, Howard
University, USA. Pesticide-free fresh leaves
of the plant were harvested, air-dried and
pulverized to a fine powder in a blender to
yield 250 g. The dry powder was mixed to a
final volume of 800 mL with deionized
water and exhaustively extracted by
maceration on an orbital shaker at room
temperature for 16 hours to afford aqueous
extract. The extract was further subjected to
liquid-liquid extraction with ethanol and the
residue further extracted with methanol
(85%) to yield methanol fraction. In an effort
to further characterize the chemical
constituents in the original sample, we
fractionated the methanol sample by solvent
partitioning with petroleum ether to yield
petroleum ether fraction. All fractions were
separately centrifuged for 10 min at 3,000
rpm, and supernatants filtered through 0.45
µm filtration units. The filtrates were then
concentrated on a Rotor Vapor (Buchi,
Brinkman Inst., NY) and dried to a powder
on a Savant Speed Vac (Holbrook, NY).
2.3 GC-MS Analysis.
Identification and analysis of chemical
compounds in VA fractions were carried on

Gas-Chromatography-Mass
Spectrometry
(GC-MS). Structural assignments were based
on analysis of fragmentation pattern of mass
spectra, direct comparison of mass spectral
data with profiles in the National Institute of
Standards and Technology (NIST2) library,
and comparisons of mass spectra with data
published in the literature. Lyophilized
samples from water, petroleum ether and
methanol fractions of VA extracts were
separately diluted with respective solvents,
filtered through 0.2 µm sterile syringe filters,
and 1 uL of each fraction solution injected
into a gas chromatograph and analyzed with
quadruple mass spectrometric detector.
2.4 Cell Culture
Human breast cancer (MDA-MB-231) cell
line was purchased from ATCC. Cells were
grown and maintained in 75 cm2 tissue
culture flasks in a humidified atmosphere at
37oC, 5 % CO2 in a Fisher Scientific waterjacketed incubator (Pittsburg, PA). Cells
were cultured in RPMI-1640 medium
supplemented with 10 % heat-inactivated
FBS (56oC, 30 min), 100 U/ml penicillin G,
100 µg/ml streptomycin and fungizone.
2.5 Cell proliferation studies (MTT assay)
The anti-proliferative effects of VA on
MDA-MB-231 breast cancer cells were
determined by MTT assay. MDA-MB-231
cells were seeded at a density of 5.0 x 103
per well in 96 well-plates with 100 µL
complete RPMI 1640 growth medium
supplemented with 10 % Fetal Bovine Serum
and antibiotic. After 24 h incubation, cells
were treated with various concentrations of
aqueous, methanol and petroleum ether
fractions of VA (0.01- 1.0 mg/mL) and
inhibition of cell proliferation assessed by
addition of 10 µl of 3-(4,5-dimethylthiazol2-yl)-2,5-diphenyltetrazolium
bromide
(MTT) reagent (5mg/mL in PBS), and the
reaction mixture incubated at 37oC, 5 % CO2
for 4 h. The mixture solution was carefully
replaced with 100 µl MTT solvent
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(isopropanol with 0.04 N HCL) to dissolve
the violet formazan crystals formed by
mitochondrial
reduction
of
MTT.
Absorbance was measured at 570 nm
wavelength on a Bio-Tek microplate reader
(Winooski, VT). Results were expressed as
means ± SD for experiments performed in
triplicate. Sample fractions were initially
dissolved in DMSO before dilution with PBS
to attain required treatment concentrations.
Percent DMSO concentration in the final
solution was < 0.25%.
2.6 Statistical Analysis
Statistical analysis was carried out using the
Analysis of Variance (ANOVA) –single
factor model followed by a two-tailed
Student’s t-test on Graphpad Prism, version
5.04., software. Data is presented as means ±
SD error of the means. P-values < 0.05 were
regarded as statistically significant.
3. RESULTS
3.1 GC-MS Analysis.
Total ion chromatogram of water fraction
revealed three major peaks at retention times
(tR) 12.64 min, 14.16 min and 14.26 min
(Fig.1a). Mass spectrum of peak at tR 12.64
min in the water fraction showed an ion at
m/z 129 (base peak), characteristic of
adipates. Other major diagnostic ions were at
m/z 259, 241 and 112. Fragment ion at m/z
241 suggests loss of a 129 mass alkoxy side
chain (-OC8H17), while m/z 112 indicate loss
of two alkoxy groups of mass 258. Ion peak
at m/z 129 indicates loss of a 241 mass
C14H25O3 ion. Fragment at m/z 258
corresponds to loss of a hydrogen and C8H17
ion of 112 mass. Fragment at m/z 223
corresponds to (M+ -146) for the loss of
adipic acid ion [-C6H10O4,]+. At m/z 57(M+313) an enoate, C18H33O4 ion was eliminated
(Fig 1b). These ions, together with a
molecular ion at m/z 370 were suggestive of
C22H42O4 molecular formula compound,
called hexanedioic acid, bis (2-ethylhexyl)
ester (2a), scheme 1a. Spectrum representing

chromatographic peak at tR 14.16 min in the
water fraction showed an intense ion at m/z
59 (base peak), typical of a long chained
fatty acid amide. This peak signifies a
McLafferty rearrangement in the alkyl
portion of an amide compound. Specific
peak ions 72, 114 and 126 are characteristic
of primary amide. Other distinct fragments
observed included m/z 97, 294, 277, 320 and
a molecular ion at m/z 337 (figure 1c). This
fragmentation pattern suggested presence of
an amide (nitrogen rule), of the formula
C22H43NO,
corresponding
to
13ZDocosenamide (2b) [35], scheme 1b.
Analysis of chromatographic peak at tR
14.26 min revealed molecular ion at m/z
410(M+) suggesting a molecular formula
C30H50 (figure 1d). Diagnostic ions were at
m/z 367(M+-C3H7), 341(M+-C5H9) and 69
(base ion). Other significant fragment ions
observed were at m/z 81, 95, 107, 121,136,
etc. Ion at m/z 341was accompanied by loss
of ion bearing a mass of 69, whereas at m/z
367 a 43 mass propyl ion was eliminated.
Fragment ion at m/z 83 corresponds to loss
of C24H39 ion of 327 mass. Ion peak at m/z
121 indicated loss of C21H37 ion. In general,
this mass ionization pattern indicates a 410
molecular mass compound of C30H50
formula, suggestive of Squalene (2c),
scheme 1c. This fragmentation pattern is
confirmed by NIST library and supported by
literature reports [24, 25]. Structural
representations of various compounds
accrued from water fraction are represented
in scheme 1d. Three major peaks were
detected in the methanol fraction at retention
times 10.28 min, 11.17 min and 11.25 min
(Fig. 2a).
Identity of compound represented at tR 10.28
min was based on major spectral ion peaks.
The molecular ion at m/z 270, as well as ion
at m/z 239(M+- 31) representing loss of a
methoxy group, are diagnostic of methyl
ester. Fragment ion at m/z 227(M+-43)
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Figure 1a.
Total ion chromatogram (TIC) of water fraction of V.amygdalina with major peaks at retention times (tR)
12.64 min, 14.16 min, and 14.26 min.

Figure 1b.
GC-MS spectrum of water fraction. Ion fragmentation pattern for spectral peak
at tR 12.64 min was specific to hexanedioic acid, bis (2-ethylhexyl) ester.

Scheme1a.
Schematic representation of mass fragmentation pattern for spectral peak at tR 12.64 min.
The fragmentation pattern was relevant to hexanedioic acid, bis (2-ethylhexyl) ester (2a).

290

Daniel A. Oyugi et al,J Biosci Tech, Vol 2 (3),2011,287-304

Figure 1c.
Mass spctrum of water fraction. Ion fragmentation pattern for
spectral peak at tR 14.16 min was specific to 13Z- docosenamide.

Scheme 1b.
(i) Schematic representation of mass fragmentation pattern for spectral peak at tR 14.16 min. The
fragments were characteristic of 13 Z-Docosenamide (2b).(ii) Mechanism of McLafferty rearrangement in
compound 2b resulted in characteristic peak at m/z 59, typical of unsaturated fatty acid amide.
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Figure 1d.
Mass spectrum of petroleum ether fraction. Ion fragmentation pattern
for spectral peak at tR 14.25 min was specific to squalene.

Scheme 1c.
Schematic representation of mass fragmentation pattern for spectral peak
at tR 14.25 min. The fragments were characteristic of Squalene (2c).
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Scheme 1d.
Chemical structures of compounds in Vernonia amygdalina water fraction: Hexanedioic acid,
bis (2-ethylhexyl) ester (2a), 13- decosenamide (2b) and Squalene (2c).

Figure 2a.
Total ion chromatogram (TIC) of methanol fraction of V.amygdalina with major
peaks at retention times (tR) 10.28 min, 11.17 min and 11.25 min.

Figure 2b.
Mass spectrum of methanol fraction. Ion fragmentation pattern for spectral
peak at tR 10.27 min was specific to hexadecanoic acid methyl ester.
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Scheme 2a.
(i) Mass fragmentation pattern for spectral peak at tR 10.28 min. The fragments were characteristic of
Hexadecanoic acid methyl ester (3a). (ii) Mechanism of γ-Hydrogen shift resulted in characteristic peak at
m/z 74, typical of long chain fatty acid methyl ester.

Figure 2c.
Mass spectrum of methanol fraction. Ion fragmentation pattern for spectral
peak at tR 11.15 min was specific to 9(Z)12(Z)15(Z)-Octadecatrienoic acid,
methyl ester (α- linolenic acid methyl ester).
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Scheme 2b.
Mass fragmentation pattern of 9(Z)12(Z)15(Z)-Octadecatrienoic acid,
methyl ester(3b), identified in V.amygdalina methanol extract.

Figure 2d.
Mass spectrum of methanol fraction. Ion fragmentation pattern for
spectral peak at tR 11.24 min was specific to phytol.
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Scheme 2c.
Schematic representation of mass fragmentation pattern of phytol(3c).

Scheme 2d.
Chemical structures of compounds in Vernonia amygdalina methanol fraction: Hexadecanoic acid
methyl ester (3a), 9(Z)12(Z)15(Z)-octadecatrienoic acid, methyl ester
(α-linolenic acid methyl ester) (3b) and Phytol (3c).
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Figure 3a.
Total ion chromatogram (TIC) of petroleum ether fraction of V.amygdalina with
major peaks at retention times (tR) 11.30 min, 11.60 min, 14.25 min, and 16.47 min.

Figure 3b.
Mass spectrum of petroleum ether fraction. Ion fragmentation pattern for
spectral peak at tR 16.47 min was specific to 7,22-Ergostadienol.
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Scheme 3a.
Schematic representation of mass fragmentation pattern of 7,22-Ergostadienol (4c)

Scheme 3b.
Chemical structures of compounds in Vernonia amygdalina petroleum ether fraction: Phytol (4a),
Squalene (4b) and 7, 22 ergostadienol (4c).
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Cell growth Inhibition (% of Control)

Figure 4.
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Vernonia amygdalina Fractions

Inhibition of MDA-MB-231 by 0.01-1 mg/mL aqueous, methanol and petroleum ether extracts of VA was
concentration dependent. Results are expressed as means ± SD for experiments performed in triplicate. VA
methanol and petroleum ether extracts significantly inhibited cell growth by 45-70 % (P < 0.001) and 70-97% (P
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< 0.001), respectively, while aqueous extract inhibition was between 11-23 % (P < 0.05), except at 1mg/mL with
71% (P < 0.001) inhibition. Cells numbers are expressed as a percentage of cells relative to 100% control.

represents loss of a C3 unit (C3H7) ion.
Prominent fragment ion at m/z 74(base peak)
is diagnostic of a long chain aliphatic fatty
acid of methyl ester, confirming that the
formation of the compound was as a result of
site-specific rearrangement of atoms, in
which γ-hydrogen from potion 4 of aliphatic
chain is transferred to the carbo-methoxy
group, through a sterically- favored sixmembered transition state (McLafferty
rearrangement) followed by Cα-Cβ bond
cleavage. Fragment at m/z 87 indicates loss
of a 183 mass C13H27 ion; m/z 129 (M+C10H21) of 141 mass; m/z 157 (M+- C8H17) of
113 mass; m/z 171(M+- C7H15); m/z 185(M+C6H13); m/z 213(M+- C4H9); m/z 227(M+C3H7); m/z 241(M+- C2H5). Other
homologous series of related ions at m/z 87,
101, 115, 129, 143, 157,171,199 etc, formed
by losses of neutral aliphatic radicals, of the
general formula [(CH2)n COOCH3)]+
indicate no occurrence of other functional
groups in the chain (figure 2b). In general,
the ions at m/z 270, 239, 227, 74, and 241
were the major product ions identifying the
compound as Hexadecanoic acid methyl
ester (3a), of formula C17H34O2, as shown in
scheme 2a. This fragmentation pattern is
consistent with interpretation by other
authors [26, 27].
Identity of compound represented by peak at
tR 11.15 min in methanol fraction was
determined by diagnostic ion peaks at m/z
79, 93, 173, 236, and 292. Ion at m/z 79 was
the base peak. Ion at m/z 108 is an omega
ion which defines methyl esters of
polyunsaturated fatty acids with an n-3
terminal group. Fragment ion at m/z 236 is
an alpha ion defining Δ9, 12 carbons as the
position of first double-bond. This ion is
formed by a cleavage at the carboxyl end of
unsaturated fatty acid to produce a fragment
containing two double bonds and a second
methylene group (minus a proton). The

molecular ion peak at m/z 292 together with
(M+-31) for the loss of methoxyl group
elements, and a hydrogen atom, was
diagnostic for polyenoic fatty acid with
methylene-interrupted unsaturation (figure
2c). These distinct ions were typical for an n3 homo-allylic unsaturated fatty acid of
molecular
formula
C19H32O2,
called
9(Z)12(Z)15(Z)-Octadecatrienoic
acid,
methyl ester (3b), (Scheme 2b).This data
was in agreement with NIST library and
literature reports [28].
Analysis of GC peak at tR 11.25 min
revealed fragment ion at m/z 278 in which
H2O is eliminated, thereby yielding a
phytadiene (C20H39) ion. Ion at m/z 123 is
typical of an acyclic-type hydrocarbon of the
formula C9H15. Ion at m/z 69 (C5H9) is a
cyclopentyl. Ion peak m/z 81(C6H9) is a 1pentene-3- yl ion. These ions are
characteristic of isoprene side chain.
Fragment at m/z 95 (C7H11) corresponds to
cyclohexene-1-methyl- ion. Intense ions at
m/z 43, 57, 71 (base peak, C5H11), and 85 are
characteristic of saturated alkanes. The
molecular ion appeared at m/z 296, agreeing
with the condensed formula C20H40O (figure
2d). Together, this fragmentation pattern is
typical of an acyclic C20 diterpene alcohol
called phytol (3c) (scheme 2c). These mass
features were consistent with library data, as
well as literature reports [29]. Complete
structures of compounds realized in the
methanol fraction are as presented in Scheme
2d below.
Three major peaks were detected in the
petroleum ether fraction at retention times
11.30 min, 11.60 min, 14.25 min, and 16.47
min. (Fig. 3a).
GC peak at tR 16.47 min in petroleum ether
fraction displayed a molecular ion at m/z
398, suggesting a structural formula
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C28H46O. Loss of CH3 from the molecule
resulted in a 383 mass C27H43O fragment.
Other characteristic ions include 300(M+C7H14) generated for allylic cleavage with
transfer of hydrogen, typical of unsaturated
sterols in C22; 273(M+-side chain), 271(M+side chain-2H), 255(M+-side chain H2O),229(M+-fission of D ring-side chain-H)
diagnostic for side chain in C17, 213(fission
of D ring-H2O) and 145(M+-H2O- fission of
C ring- methyl group) (figure 3b). In
addition, the minor ion peak at m/z 246 is
characteristic of Δ7-3-hydroxyandrostene
templates, which, together with peaks at m/z
300 and 229 corresponding to unsaturation in
C22, confirm the identity of the compound as
7,22-ergostadienol (4c), Scheme 3a. Overall
structures of compounds in the petroleum
ether fraction are represented as shown in
scheme 3b, below.
Examination of GC elution order of VA
compounds reveals some patterns that
influence their behavior on GC. First, most
low molecule weight compounds eluted
earlier than high molecular weight
compounds. For example, at 12.64 retention
time (tR), compound 2a (C22, 370MW)
eluted 1.62 min earlier than compound 2c
(C30, 410MW). Compound 2b (C22, MW
337) eluted 0.1 min earlier than 2c. This
observation is the same for all compounds in
the water extract, except for compound 2b
(C22, MW 337) which eluted 1.52 min later
than 2a, despite its low molecular weight.
This difference may be due to polar property
of 2b.
At 10.28 min, compound 3a (C17, 270 MW)
in methanol fraction eluted 0.89 min and
0.97 min earlier than compounds 3b (C19,
292MW) and 3c (C20, 296 MW),
respectively. A similar linear relationship
exists for compounds in petroleum ether
fractions, with compound 4a (C20, MW 296)
at 11.30 min retention time, eluting 2.95 min

and 5.17 earlier than compounds 4b (C30,
410MW)
and
4c
(C28,
398MW),
respectively. Despite the lower molecular
weight of 4c, relative to 4b, compound 4c
eluted at a higher retention time than 4b.
This difference may be attributed to low
unsaturation of its side chain. Secondly, low
molecular weight saturated compounds 2a
and 3a eluted earlier than high molecular
weight unsaturated compounds 2b- 4c.These
observations generally indicate a direct
relationship between molecular weight or
carbon length, and compound’s retention
time on GC. Straight chain fatty acid
alcohols 3c and 4a eluted earlier than esters
and terpenes of analogous structures 3b and
4b.
Thirdly,
unsaturated
polycyclic
compound 4c was retained on GC longer
than straight chain unsaturated terpenes 4a,
and 4b, table 1. This may be attributed to the
nature of its side chain groups.
3.2 Chemical composition
The chemical composition of VA fractions
was studied by gas chromatography coupled
to
mass
spectrometry.
Constituent
compounds were detected and their
composition recorded as shown in Table 1.
Our results showed the presence of aliphatic
acid esters, terpene, diterpene alcohol and
phytostanol in the fractions. Diterpene
alcohol was the major chemical group in VA
fractions. Phytol 3c, 4a were the main
diterpene alcohols in methanol fraction, and
petroleum ether fraction. Terpenes, fatty acid
amide and phytostanol were the least
abundant groups in the fractions. Compound
2c, a terpene, was detected in the aqueous
fraction and 4b in the petroleum ether
fraction. Compound 2b, a fatty acid amide,
was found in aqueous fraction. Finally,
compound 4c, a phytostanol, was detected in
petroleum ether fraction. These data
demonstrate similarities and differences in
the occurrence of compounds in Vernonia
amygdalina fractions. The aliphatic acid
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esters occurred in both aqueous and
methanol fractions. Terpenes occurred in
both aqueous and petroleum ether fractions
but absent in the methanol fraction, with
higher quantities present in the water fraction
than in the petroleum ether fraction.
Diterpene alcohols were obtained in both
methanol and petroleum ether fractions with
higher levels in petroleum ether fraction than
in methanol fraction. Fatty acid amide and
phytostanol occurred in the water and
petroleum ether fractions.
3.3 Cell growth Inhibition
MDA-MB-231 human breast cancer cells
exhibited
significant
VA-induced
suppression
of
proliferation.
A
concentration-dependent inhibition of cell
growth, relative to 100% control, was
observed for all fractions. At equal
concentration of 0.01 mg/mL aqueous,
methanol and petroleum ether fractions
inhibited cell growth by 11%, 45%, and
70%, respectively. At 0.1 mg/mL, the
fractions inhibited growth by 13.7%, 55.2%
and 79.4%, respectively, while at 0.5 mg/mL
cell growth inhibition was by 23.5%, 69.7%,
and 83.6%, respectively. At the highest
concentration (1mg/mL), fractions induced
growth inhibition by 71.2%, 70.0% and
97.1%, respectively. In general, at equal
concentration of 0.01-1.0 mg/mL, aqueous
fraction elicited lower inhibition rate,
representing 11-23 % (P < 0.05) of total
inhibition, except at 1 mg/mL (71% ;P <
0.001). In contrast, methanol and petroleum
ether fractions elicited greater inhibition,
representing 45-70% (P < 0.001) and 7097% (P < 0.001), respectively, at equal
concentrations (0.01-1mg/mL), figure 4.
4. DISCUSSION
As a source of anti-cancer agents, plants and
other natural products with medicinal
properties continue to be active areas of
research, offering leads to the development

of conventional drugs [30, 31]. Improved
interest and growth of natural product-based
drug discovery has been influenced by high
costs, side effects, and therapeutic
implications of conventional medicine [32,
33].
Sample analyses by GC-MS showed
compounds such as squalene (2c)
represented by peak at 14.26 min in the
water fraction. Squalene is a terpenoid and a
biological precursor of steroids with
activities against colon, lung and skin
cancers. It is also a potent cytoprotective
agent against chemotherapeutic toxicities
[34-38]. 13(Z)-decosenamide (erucamide)
(2b), also detected in the water fraction is a
fatty acid amide known to enhance
neovascularization in regenerating skeletal
muscle [39, 40], and modulate water balance
in the visceral organs and in the
cerebrospinal fluid [41].
Phytol (3c) in the methanol and petroleum
ether fractions is a diterpene alcohol which
functions as a precursor for Vitamins E and
K1 and an antioxidant and a preventive agent
against epoxide-induced breast cancer
carcinogenesis [42]. It’s also an effective
vaccine adjuvant with no adverse autoimmune effects [43]. Hexadecanoic acid
methyl ester (3a), also known as Methyl
palmitate, in the methanol fraction is an
aliphatic acid ester reported to cause growth
inhibition and apoptosis induction in human
gastric cancer cells [44]. 9(Z)12(Z)15(Z)octadecatrienoic acid, methyl ester (3b), also
known as α- linolenic acid methyl ester, is an
aliphatic acid ester known to inhibit
proliferation of ER-positive and ERnegative breast cancer cells [45]. It is also a
potent antiangiogenic agent in colorectal
cancer and in HUVEC cells [46]. 7, 22
ergostadienol (4c) detected in petroleum
ether fraction is a phytostanol of the
brassicasterol family reported to inhibit
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promotion of carcinogenesis in urinary
bladder [47].
Extraction and sequential fractionation of
VA water extract by solvent partitioning
significantly increased inhibition rate of
cancer cell growth. The original extract
(water) exerted growth inhibition (P < 0.05)
of 11-23 % at 0.01mg/mL. Further
fractionation of water extract to obtain
methanol fraction improved the rate of
inhibition by 45-70% (P < 0.001) at similar
concentrations. Successive fractionation and
purification of methanol fraction to afford
petroleum ether fraction yielded greater
inhibition rate of 70-97% (P < 0.001) at
same concentrations. We may conclude that
petroleum ether and methanol can
differentially extract active molecules
capable of acting synergistically to elicit
stronger cell growth inhibition compared to
water-soluble extract. It is also likely that
variation in quantity, quality and activity of
chemical components in VA fractions may
account for the differences observed in
growth-inhibitory activities of the fractions.
5. CONCLUSION
Vernonia amygdalina is a dietary medicinal
plant used for many diseases and infections.
Phytochemical analysis by GC-MS revealed
presence of fatty acid esters, fatty acid
amide, terpenoids, diterpene alcohols and
phytostanol as major compound groups in
the aqueous, methanol and petroleum ether
fractions. Compositional variation in
quantities, qualities and structural features
may influence compounds’ behavior on GCMS, as well as bioactivities of their precursor
fractions.
These
fractions
displayed
concentration-dependant growth inhibition
activities on hormone-independent MDAMB-231 breast cancer cells, in Vitro, with
organic fractions eliciting higher growth
inhibition than aqueous fraction, further
indicating a direct relationship between serial
fractionation and activity. The identified

compounds in this study have important
pharmacological functions against various
neoplastic diseases. Studies aimed at further
isolation to identify additional components
and determine mechanism of action of
Vernonia amygdalina compounds would be
necessary.
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